Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)
Conditions: Safety Issues; Immunogenicity Interventions: Biological: Vi-DT Typhoid Conjugate Vaccine; Biological: PQed Typhoid Conjugate Vaccine; Biological: Vi Polysaccharide Vaccine Sponsor: PT Bio Farma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2019 Category: Research Source Type: clinical trials